|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
The Week in Review: Fosun Pharma Given OK for Hong Kong IPO
April 14, 2012
Shanghai Fosun Pharma received approval for a Hong Kong IPO that will raise between $600 million and $800 million; China Cord Blood Group announced Kohlberg Kravis Roberts will invest $65 million into... Read More
from ChinaBio® Today
|